Sofie Priem

559 total citations
6 papers, 435 citations indexed

About

Sofie Priem is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Hepatology. According to data from OpenAlex, Sofie Priem has authored 6 papers receiving a total of 435 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Immunology and 3 papers in Hepatology. Recurrent topics in Sofie Priem's work include Hepatitis C virus research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Hepatitis B Virus Studies (2 papers). Sofie Priem is often cited by papers focused on Hepatitis C virus research (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Hepatitis B Virus Studies (2 papers). Sofie Priem collaborates with scholars based in Belgium, Netherlands and South Africa. Sofie Priem's co-authors include Josefin-Beate Holz, Stefaan Rossenu, Jan Roodt, Hans Ulrichts, Erik Depla, Ann Union, Jens Bukh, Rodney S. Russell, Kristina Faulk and Jean‐Christophe Meunier and has published in prestigious journals such as Blood, Hepatology and Journal of Virology.

In The Last Decade

Sofie Priem

6 papers receiving 423 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sofie Priem Belgium	5	173	152	152	147	121	6	435
Takuma Miura Japan	12	40 0.2×	51 0.3×	29 0.2×	49 0.3×	81 0.7×	42	441
Consuelo Comar Italy	5	341 2.0×	232 1.5×	20 0.1×	134 0.9×	50 0.4×	7	468
Shijun Chen China	11	111 0.6×	165 1.1×	20 0.1×	137 0.9×	35 0.3×	20	400
M. Fort France	7	204 1.2×	165 1.1×	21 0.1×	126 0.9×	25 0.2×	10	372
Patricia Palladinetti Australia	9	261 1.5×	228 1.5×	21 0.1×	202 1.4×	62 0.5×	9	617
Diahann T. S. L. Jansen Netherlands	13	41 0.2×	70 0.5×	69 0.5×	190 1.3×	53 0.4×	20	401
M Gripenberg Finland	14	28 0.2×	75 0.5×	228 1.5×	175 1.2×	31 0.3×	32	509
Helen Cooksley United Kingdom	12	481 2.8×	464 3.1×	14 0.1×	207 1.4×	17 0.1×	14	706
G. J. Laundy United Kingdom	11	29 0.2×	68 0.4×	48 0.3×	223 1.5×	86 0.7×	31	415
A O Haakenstad United States	8	27 0.2×	25 0.2×	125 0.8×	181 1.2×	71 0.6×	9	447

Countries citing papers authored by Sofie Priem

Since Specialization

Citations

This map shows the geographic impact of Sofie Priem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sofie Priem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sofie Priem more than expected).

Fields of papers citing papers by Sofie Priem

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sofie Priem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sofie Priem. The network helps show where Sofie Priem may publish in the future.

Co-authorship network of co-authors of Sofie Priem

This figure shows the co-authorship network connecting the top 25 collaborators of Sofie Priem. A scholar is included among the top collaborators of Sofie Priem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sofie Priem. Sofie Priem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

1.

Sandra, Koen, Kjell A. Mortier, Lucie Jorge, et al.. (2014). LC–MS/MS Quantification of Next-Generation Biotherapeutics: A Case Study for an IgE Binding Nanobody in Cynomolgus Monkey Plasma. Bioanalysis. 6(9). 1201–1213. 8 indexed citations

2.

Callewaert, Filip, Jan Roodt, Hans Ulrichts, et al.. (2012). Evaluation of efficacy and safety of the anti-VWF Nanobody ALX-0681 in a preclinical baboon model of acquired thrombotic thrombocytopenic purpura. Blood. 120(17). 3603–3610. 106 indexed citations

3.

Verstrepen, Babs E., Erik Depla, Christine S. Rollier, et al.. (2011). Clearance of Genotype 1b Hepatitis C Virus in Chimpanzees in the Presence of Vaccine-Induced E1-Neutralizing Antibodies. The Journal of Infectious Diseases. 204(6). 837–844. 36 indexed citations

4.

Ulrichts, Hans, Karen Silence, Anne Schoolmeester, et al.. (2011). Antithrombotic drug candidate ALX-0081 shows superior preclinical efficacy and safety compared with currently marketed antiplatelet drugs. Blood. 118(3). 757–765. 140 indexed citations

5.

Meunier, Jean‐Christophe, Rodney S. Russell, Vera Goossens, et al.. (2007). Isolation and Characterization of Broadly Neutralizing Human Monoclonal Antibodies to the E1 Glycoprotein of Hepatitis C Virus. Journal of Virology. 82(2). 966–973. 142 indexed citations

6.

Depla, Erik, Sofie Priem, Ernst J. Verschoor, et al.. (2003). 247 Acute resolving infection after E1 but not after E2 prophylactic vaccination and heterologous challenge with 100 CID of HCV subtype 1B strain HC-J4. Hepatology. 38. 276–276. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact